Thilo Bayrhoffer

Thilo Bayrhoffer is a distinguished professional with extensive experience across various sectors, primarily in consulting and healthcare. Currently serving as a Co-opted Member of the Access to Treatment/Generics Task Force of the Medical Therapies Commission for the ILAE International League Against Epilepsy since February 2023, Thilo Bayrhoffer has also held significant roles as Executive Advisor and Member of the Board at Speratum since December 2016, and as Partner and Managing Director at EmPartners since October 2009. Academic credentials include a Program on Negotiation at Harvard Law School in 2019, an MBA from the University of Rochester - Simon Business School (2000-2002), and an MD from Johannes Gutenberg University Mainz (1993-1999). Previous positions include Managing Partner at SwissCore Group and Senior Director of U.S. Operations at PharmARC Analytic Solutions.